Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NewGenIvf Group ( (NIVF) ) has shared an update.
On July 4, 2025, NewGenIvf Group Limited’s Board of Directors approved an amendment to increase the company’s authorized shares to an unlimited number, effective immediately. This strategic move aims to enhance the company’s flexibility in capital management. Additionally, on July 5, 2025, the Board approved a reverse stock split at a ratio of one for five to comply with Nasdaq’s minimum bid price requirement. This adjustment, effective around August 4, 2025, is intended to maintain the company’s Nasdaq listing, impacting the trading of its Class A Ordinary Shares.
More about NewGenIvf Group
NewGenIvf Group Limited operates in the healthcare industry, focusing on reproductive health services. The company is known for providing advanced fertility treatments and solutions, catering to a global market with a particular emphasis on innovative reproductive technologies.
Average Trading Volume: 3,881,592
Technical Sentiment Signal: Sell
Current Market Cap: $4M
See more insights into NIVF stock on TipRanks’ Stock Analysis page.